NV

Nevro

- NYSE:NVRO
Last Updated 2024-03-26

Indeed Snapshot

Track Nevro reviews on Indeed to uncover insights on employee sentiment
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 29th, 2022 12:00AM Open Nevro Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.40 21.00 21.00 3.30 3.50 2.70 2.90 3.10 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 29th, 2022 01:56PM Aug 29th, 2022 01:56PM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 28th, 2022 12:00AM Open Nevro Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.40 21.00 21.00 3.30 3.50 2.70 2.90 3.10 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 28th, 2022 07:32AM Aug 28th, 2022 07:32AM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 27th, 2022 12:00AM Open Nevro Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.40 21.00 21.00 3.30 3.50 2.70 2.90 3.10 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 27th, 2022 06:21AM Aug 27th, 2022 06:21AM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 25th, 2022 12:00AM Open Nevro Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.20 13.00 13.00 3.10 3.70 2.30 2.60 3.00 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 25th, 2022 10:54AM Aug 25th, 2022 10:54AM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 23rd, 2022 12:00AM Open Nevro Corporation Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.20 13.00 13.00 3.10 3.70 2.30 2.60 3.00 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 23rd, 2022 12:46PM Aug 23rd, 2022 12:46PM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 21st, 2022 12:00AM Open Nevro Corporation Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.20 13.00 13.00 3.10 3.70 2.30 2.60 3.00 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 21st, 2022 02:32PM Aug 21st, 2022 02:32PM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 20th, 2022 12:00AM Open Nevro Corporation Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.20 13.00 13.00 3.10 3.70 2.30 2.60 3.00 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 20th, 2022 04:12PM Aug 20th, 2022 04:12PM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 19th, 2022 12:00AM Open Nevro Corporation Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.20 13.00 13.00 3.10 3.70 2.30 2.60 3.00 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 19th, 2022 02:31PM Aug 19th, 2022 02:31PM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 18th, 2022 12:00AM Open Nevro Corporation Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.20 13.00 13.00 3.10 3.70 2.30 2.60 3.00 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 18th, 2022 07:09AM Aug 18th, 2022 07:09AM Nevro Health Care Health Care Equipment & Services
nyse:nvro https://www.indeed.com/cmp/nevro-corporation Aug 17th, 2022 12:00AM Open Nevro Corporation Nevro is a medical device company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform for the treatment of chronic pain. We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has advanced the state of spinal cord stimulation (SCS). We explored beyond traditional SCS frequencies (40–60 Hz) in search of better therapeutic outcomes. Combining high frequency at 10 kHz with a unique waveform and a specific treatment algorithm resulted in HF10 therapy: a paresthesia-free treatment proven to provide more pain relief to more patients in more pain areas.1 The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States. RRv1_25M_100M Redwood City 3.10 12.00 12.00 3.00 3.60 2.20 2.50 2.90 6.00 About two weeks 9.00 MEDIUM 6.00 AVERAGE Aug 17th, 2022 11:53AM Aug 17th, 2022 11:53AM Nevro Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.